Daniel Drozd
Advertisement
Articles by Daniel Drozd
Advertisement
Latest Updated Articles
24 Real-world Use of Neratinib Post-Pertuzumab (P) and –Ado-Trastuzumab Emtansine (T-DM1)Published: April 18th 2022 | Updated: April 19th 2022
Advertisement
Advertisement
Trending on CancerNetwork
1
CHMP Recommends Pembrolizumab Regimen for Approval in Pretreated PROC
2
FDA Grants Tentative Approval to PNT2003 for GEP-NETs
3
Evaluating Thyroid Cancer Risk After GLP-1 Receptor Agonist Administration
4
Prioritizing Early Detection to Improve Survival Outcomes in Pancreatic Cancer
5